Allena Pharmaceuticals, Inc.

ALNAQ · OTC
Analyze with AI
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Operating Activities
Net Income-$33-$33-$47-$36
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$4$4$3$2
Change in WC-$1-$0$0$1
Other Non-Cash-$15$1$0$1
Operating Cash Flow-$46-$28-$44-$32
Investing Activities
PP&E Inv.-$1-$1-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$1-$1-$0-$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$41$34$0$0
Stock Repurch.$0$0$0-$0
Dividends Paid$0$0$0$0
Other Fin. Act.$41$34$12-$1
Financing Cash Flow$41$34$12-$1
Forex Effect$0$0$0$0
Net Chg. in Cash-$5$5-$32-$33
Supplemental Information
Beg. Cash$35$30$62$94
End Cash$30$35$30$62
Free Cash Flow-$46-$29-$44-$32